tirzepatide in hfpef Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Tirzepatide for Heart Failure in

While GLP-1 and GIP agonists are effective for many people, they may not be suitable for everyone

The Work Group found no specific evidence of adverse drug effects associated with IV L-carnitine in patients with CKD

The Berlin definition, currently regarded as the gold standard, dominates the diagnostic landscape for ARDS

Noting how you tolerate each step, including any nausea or digestive changes, gives your prescriber the information to decide whether to hold, advance, or adjust

This article examines the evidence on Ozempic and oestrogen, explores indirect effects mediated through weight loss, and provides guidance for women considering or taking this medication